Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1)

PLoS Neglected Tropical Diseases

Volumn 7, Issue 10, 2013, Pages

  Arnott, Alicia ^a   Mueller, Ivo ^b,c,d   Ramsland, Paul A ^a,d,e,f   Siba, Peter M ^g   Reeder, John C ^a,h   Barry, Alyssa E ^c,d  

^a BURNET INSTITUTE   (Australia)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f CURTIN UNIVERSITY   (Australia)

^g PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^h MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1; UNCLASSIFIED DRUG;

ARTICLE; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; IMMUNE RESPONSE; MALARIA; NUCLEOTIDE SEQUENCE; PARASITE IDENTIFICATION; PHYLOGENY; POLYMERASE CHAIN REACTION; POPULATION STRUCTURE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DNA, PROTOZOAN; FEMALE; HAPLOTYPES; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, VIVAX; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGEOGRAPHY; PLASMODIUM VIVAX; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, DNA; WORLD HEALTH; YOUNG ADULT;

EID: 84887293710     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002506     Document Type: Article

References (89)

1. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, et al. (2010) The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4: e774.
2. Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, et al. (2008) Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 5: e127.
3. Alexandre MA, Ferreira CO, Siqueira AM, Magalhaes BL, Mourao MP, et al. (2010) Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis 16: 1611-1614.
4. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, et al. (2009) Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555-566.
5. Feachem RGA, with A.A Phillips and G.A Targett (eds) (2009) Shrinking the Malaria Map: A Prospectus on Malaria Elimination. San Francisco: The Global Health Group, Global Health Sciences, University of California, San Francisco.
6. Olivera-Ferreira J, Lacerda M, Brasil P, Ladislau JL, Tauil PL, et al. (2010) Malaria in Brazil: an overview. Malaria J 9: 115.
7. Kasehagen LJ, Mueller I, McNamara DT, Bockarie MJ, Kiniboro B, et al. (2006) Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis. Am J Trop Med Hyg 75: 588-596.
8. Carme B, Ardillon V, Girod R, Grenier C, Joubert M, et al. (2009) Update on the epidemiology of malaria in French Guiana. Med Trop (Mars) 69: 19-25.
9. WHO (2012) World Malaria Report 2012. Geneva: World Health Organisation.
10. Carlton JM, Sina BJ, Adams JH, (2011) Why is Plasmodium vivax a neglected tropical disease? PLoS Negl Trop Dis 5: e1160.
11. Remarque EJ, Faber BW, Kocken CH, Thomas AW, (2008) Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol 24: 74-84.
12. Bai T, Becker M, Gupta A, Strike P, Murphy VJ, et al. (2005) Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. Proc Natl Acad Sci U S A 102: 12736-12741.
13. Galinski MR, Barnwell JW, (2008) Plasmodium vivax: who cares? Malar J 7 Suppl 1: S9.
14. Hodder AN, Crewther PE, Matthew ML, Reid GE, Moritz RL, et al. (1996) The disulfide bond structure of Plasmodium apical membrane antigen-1. J Biol Chem 271: 29446-29452.
15. Alexander DL, Mital J, Ward GE, Bradley P, Boothroyd JC, (2005) Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles. PLoS Pathog 1: e17.
16. Lamarque M, Besteiro S, Papoin J, Roques M, Vulliez-Le Normand B, et al. (2011) The RON2-AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites. PLoS Pathog 7: e1001276.
17. Vulliez-Le Normand B, Tonkin ML, Lamarque MH, Langer S, Hoos S, et al. (2012) Structural and functional insights into the malaria parasite moving junction complex. PLoS Pathog 8: e1002755.
18. Mital J, Meissner M, Soldati D, Ward GE, (2005) Conditional expression of Toxoplasma gondii apical membrane antigen-1 (TgAMA1) demonstrates that TgAMA1 plays a critical role in host cell invasion. Mol Biol Cell 16: 4341-4349.
19. Olivieri A, Collins CR, Hackett F, Withers-Martinez C, Marshall J, et al. (2011) Juxtamembrane shedding of Plasmodium falciparum AMA1 is sequence independent and essential, and helps evade invasion-inhibitory antibodies. PLoS Pathog 7: e1002448.
20. Mitchell GH, Thomas AW, Margos G, Dluzewski AR, Bannister LH, (2004) Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells. Infect Immun 72: 154-158.
21. Howell SA, Well I, Fleck SL, Kettleborough C, Collins CR, et al. (2003) A single malaria merozoite serine protease mediates shedding of multiple surface proteins by juxtamembrane cleavage. J Biol Chem 278: 23890-23898.
22. Mufalo BC, Gentil F, Bargieri DY, Costa FT, Rodrigues MM, et al. (2008) Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infection. Microbes Infect 10: 1266-1273.
23. Gentil F, Bargieri DY, Leite JA, Francoso KS, Patricio MB, et al. (2010) A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice. Vaccine 28: 6183-6190.
24. Hodder AN, Crewther PE, Anders RF, (2001) Specificity of the protective antibody response to apical membrane antigen 1. Infect Immun 69: 3286-3294.
25. Kennedy MC, Wang J, Zhang Y, Miles AP, Chitsaz F, et al. (2002) In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect Immun 70: 6948-6960.
26. Kocken CH, Withers-Martinez C, Dubbeld MA, van der Wel A, Hackett F, et al. (2002) High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect Immun 70: 4471-4476.
27. Coley AM, Gupta A, Murphy VJ, Bai T, Kim H, et al. (2007) Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. PLoS Pathog 3: 1308-1319.
28. Macraild CA, Anders RF, Foley M, Norton RS, (2011) Apical membrane antigen 1 as an anti-malarial drug target. Curr Top Med Chem 11: 2039-2047.
29. Ord RL, Tami A, Sutherland CJ, (2008) ama1 genes of sympatric Plasmodium vivax and P. falciparum from Venezuela differ significantly in genetic diversity and recombination frequency. PLoS One 3: e3366.
30. Escalante AA, Grebert HM, Chaiyaroj SC, Magris M, Biswas S, et al. (2001) Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum. X. Asembo Bay Cohort Project. Mol Biochem Parasitol 113: 279-287.
31. Polley SD, Conway DJ, (2001) Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene. Genetics 158: 1505-1512.
32. Gunasekera AM, Wickramarachchi T, Neafsey DE, Ganguli I, Perera L, et al. (2007) Genetic diversity and selection at the Plasmodium vivax apical membrane antigen-1 (PvAMA-1) locus in a Sri Lankan population. Mol Biol Evol 24: 939-947.
33. Moon SU, Na BK, Kang JM, Kim JY, Cho SH, et al. (2010) Genetic polymorphism and effect of natural selection at domain I of apical membrane antigen-1 (AMA-1) in Plasmodium vivax isolates from Myanmar. Acta Trop 114: 71-75.
34. Rodrigues MH, Rodrigues KM, Oliveira TR, Comodo AN, Rodrigues MM, et al. (2005) Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. Int J Parasitol 35: 185-192.
35. Figtree M, Pasay CJ, Slade R, Cheng Q, Cloonan N, et al. (2000) Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes. Mol Biochem Parasitol 108: 53-66.
36. Remarque EJ, Faber BW, Kocken CH, Thomas AW, (2008) A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits. Infect Immun 76: 2660-2670.
37. Coley AM, Parisi K, Masciantonio R, Hoeck J, Casey JL, et al. (2006) The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. Infect Immun 74: 2628-2636.
38. Takala SL, Coulibaly D, Thera MA, Batchelor AH, Cummings MP, et al. (2009) Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Sci Transl Med 1: 2ra5.
39. Conway DJ, Cavanagh DR, Tanabe K, Roper C, Mikes ZS, et al. (2000) A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med 6: 689-692.
40. Weedall GD, Conway DJ, (2010) Detecting signatures of balancing selection to identify targets of anti-parasite immunity. Trends Parasitol 26: 363-369.
41. Mueller I, Widmer S, Michel D, Maraga S, McNamara DT, et al. (2009) High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea. Malar J 8: 41.
42. Koepfli C, Antao T, Barry A, Timinao L, SIba P, et al. (2013) A large Plasmodium vivax reservoir and little population structure in the South Pacific. PLoS One 8: e66041.
43. Schultz L, Wapling J, Mueller I, Ntsuke PO, Senn N, et al. (2010) Multilocus haplotypes reveal variable levels of diversity and population structure of Plasmodium falciparum in Papua New Guinea, a region of intense perennial transmission. Malar J 9: 336.
44. Arnott A, Barnadas C, Senn N, Siba P, Mueller I, et al. (2013) High genetic diversity of Plasmodium vivax on the north coast of Papua New Guinea. American Journal of Tropical Medicine and Hygiene 89: 188-94.
45. Koepfli C, Ross A, Kiniboro B, Smith TA, Zimmerman PA, et al. (2011) Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea. PLoS Negl Trop Dis 5: e1424.
46. Cheng Q, Saul A, (1994) Sequence analysis of the apical membrane antigen I (AMA-1) of Plasmodium vivax. Mol Biochem Parasitol 65: 183-187.
47. Gene Codes Corporation Sequencher® version 5.0 sequence analysis software. Ann Arbor, MI, USA.
48. Putaporntip C, Jongwutiwes S, Grynberg P, Cui L, Hughes AL, (2009) Nucleotide sequence polymorphism at the apical membrane antigen-1 locus reveals population history of Plasmodium vivax in Thailand. Infect Genet Evol 9: 1295-1300.
49. Rajesh V, Elamaran M, Vidya S, Gowrishankar M, Kochar D, et al. (2007) Plasmodium vivax: genetic diversity of the apical membrane antigen-1 (AMA-1) in isolates from India. Exp Parasitol 116: 252-256.
50. Ntumngia FB, McHenry AM, Barnwell JW, Cole-Tobian J, King CL, et al. (2009) Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development. Am J Trop Med Hyg 80: 218-227.
51. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
52. Glaubitz JC, (2004) convert: A user-friendly program to reformat diploid genotypic data for commonly used population genetic software packages. Molecular Ecology Notes 4: 309-310.
53. Librado P, Rozas J, (2009) DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25: 1451-1452.
54. Nei M, Gojobori T, (1986) Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3: 418-426.
55. Tajima F, (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123: 585-595.
56. Nobrega de Sousa T, Carvalho LH, Alves de Brito CF, (2011) Worldwide genetic variability of the Duffy binding protein: insights into Plasmodium vivax vaccine development. PLoS One 6: e22944.
57. Cockerham CC, Weir BS, (1984) Covariances of relatives stemming from a population undergoing mixed self and random mating. Biometrics 40: 157-164.
58. Cockerham CC, (1973) Analyses of gene frequencies. Genetics 74: 679-700.
59. Rousset F, (2008) genepop'007: a complete re-implementation of the genepop software for Windows and Linux. Mol Ecol Resour 8: 103-106.
60. Raymond MR, (1995) F (1995) GENEPOP (version 1.2): population genetics software for exact tests and ecumenicis. Journal of Heredity 86: 248-249.
61. Pritchard JK, Stephens M, Donnelly P, (2000) Inference of population structure using multilocus genotype data. Genetics 155: 945-959.
62. Hubisz MJ, Falush D, Stephens M, Pritchard JK, (2009) Inferring weak population structure with the assistance of sample group information. Mol Ecol Resour 9: 1322-1332.
63. Evanno G, Regnaut S, Goudet J, (2005) Detecting the number of clusters of individuals using the software STRUCTURE: a simulation study. Mol Ecol 14: 2611-2620.
64. Bandelt HJ, Forster P, Rohl A, (1999) Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 16: 37-48.
65. Sali A, Blundell TL, (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815.
66. Dutta S, Lee SY, Batchelor AH, Lanar DE, (2007) Structural basis of antigenic escape of a malaria vaccine candidate. Proc Natl Acad Sci U S A 104: 12488-12493.
67. Dutta S, Dlugosz LS, Clayton JW, Pool CD, Haynes JD, et al. (2010) Alanine mutagenesis of the primary antigenic escape residue cluster, c1, of apical membrane antigen 1. Infect Immun 78: 661-671.
68. Crabb BS, Beeson JG, Amino R, Menard R, Waters A, et al. (2012) Perspectives: The missing pieces. Nature 484: S22-23.
69. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, et al. (2012) The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum. Nat Genet 44: 1046-50.
70. Osier FH, Weedall GD, Verra F, Murungi L, Tetteh KK, et al. (2010) Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya. Infect Immun 78: 4625-4633.
71. Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, et al. (2012) A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 6: e1814.
72. Chenet SM, Schneider KA, Villegas L, Escalante AA, (2012) Local population structure of Plasmodium: impact on malaria control and elimination. Malar J 11: 412.
73. Jongwutiwes S, Putaporntip C, Iwasaki T, Ferreira MU, Kanbara H, et al. (2005) Mitochondrial genome sequences support ancient population expansion in Plasmodium vivax. Mol Biol Evol 22: 1733-1739.
74. Grynberg P, Fontes CJ, Hughes AL, Braga EM, (2008) Polymorphism at the apical membrane antigen 1 locus reflects the world population history of Plasmodium vivax. BMC Evol Biol 8: 123.
75. Dias S, Longacre S, Escalante AA, Udagama-Randeniya PV, (2011) Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka. Infect Genet Evol 11: 145-156.
76. Kocken CH, Narum DL, Massougbodji A, Ayivi B, Dubbeld MA, et al. (2000) Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion. Mol Biochem Parasitol 109: 147-156.
77. Chesne-Seck ML, Pizarro JC, Vulliez-Le Normand B, Collins CR, Blackman MJ, et al. (2005) Structural comparison of apical membrane antigen 1 orthologues and paralogues in apicomplexan parasites. Mol Biochem Parasitol 144: 55-67.
78. Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, et al. (2013) The Evolutionary History of Plasmodium vivax as Inferred from Mitochondrial Genomes: Parasite Genetic Diversity in the Americas. Mol Biol Evol 30: 2050-2064.
79. Zakeri S, Sadeghi H, Mehrizi AA, Djadid ND, (2013) Population genetic structure and polymorphism analysis of gene encoding apical membrane antigen-1 (AMA-1) of Iranian Plasmodium vivax wild isolates. Acta Trop 126: 269-79.
80. Dias S, Somarathna M, Manamperi A, Escalante AA, Gunasekera AM, et al. (2011) Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka. Vaccine 29: 7491-7504.
81. Duan J, Mu J, Thera MA, Joy D, Kosakovsky Pond SL, et al. (2008) Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design. Proc Natl Acad Sci U S A 105: 7857-7862.
82. Barry AE, Schultz L, Buckee CO, Reeder JC, (2009) Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum. PLoS One 4: e8497.
83. Mu J, Joy DA, Duan J, Huang Y, Carlton J, et al. (2005) Host switch leads to emergence of Plasmodium vivax malaria in humans. Mol Biol Evol 22: 1686-1693.
84. Mueller I, Genton B, Betuela I, Alpers MP, (2010) Vaccines against malaria: perspectives from Papua New Guinea. Hum Vaccin 6: 17-20.
85. Dempwolff O, (1904) Bericht über eine Malaria-Expedition nach Deutsch-Neu- Guinea. Zeitsohr f Hyg u Infectionskrankh 47: 81-132.
86. Rosanas-Urgell A, Lin E, Manning L, Rarau P, Laman M, et al. (2012) Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study. PLoS Med 9: e1001305.
87. Drew DR, Hodder AN, Wilson DW, Foley M, Mueller I, et al. (2012) Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria. PLoS One 7: e51023.
88. Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, et al. (2011) A field trial to assess a blood-stage malaria vaccine. N Engl J Med 365: 1004-1013.
89. Schwartz L, Brown GV, Genton B, Moorthy VS, (2012) A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J 11: 11.